Yesterday hVIVO (HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announced that Octopus Investments had raised its
Yesterday hVIVO (HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announced that Octopus Investments had raised its
Tirupati Graphite (TGR), the specialist graphite producer and developer of sustainable new age materials, announced its Audited Final Results for the year ended 31 March 2023 (FY23).